Survival Impact of Adjuvant Chemotherapy for Resected Locally Advanced Rectal Adenocarcinoma.

Autor: Tay RY; Department of Medical Oncology, Eastern Health, Box Hill, Australia., Jamnagerwalla M; Department of Surgery, Eastern Health, Box Hill, Australia., Steel M; Department of Surgery, Eastern Health, Box Hill, Australia., Wong HL; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; University of Melbourne, Melbourne, Australia., McKendrick JJ; Department of Medical Oncology, Eastern Health, Box Hill, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia., Faragher I; Western Health, Footscray, Australia., Kosmider S; Western Health, Footscray, Australia., Hastie I; The Royal Melbourne Hospital, Parkville, Australia., Desai J; The Royal Melbourne Hospital, Parkville, Australia., Tacey M; The Royal Melbourne Hospital, Parkville, Australia., Gibbs P; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; University of Melbourne, Melbourne, Australia; Western Health, Footscray, Australia; The Royal Melbourne Hospital, Parkville, Australia., Wong R; Department of Medical Oncology, Eastern Health, Box Hill, Australia; Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia. Electronic address: Rachel.Wong@monash.edu.

Publikováno v: Clinical colorectal cancer [Clin Colorectal Cancer] 2017 Jun; Vol. 16 (2), pp. e45-e54. Date of Electronic Publication: 2016 Oct 06.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Time course of safety and efficacy of aflibercept in combination with FOLFIRI in patients with metastatic colorectal cancer who progressed on previous oxaliplatin-based therapy.

Autor: Ruff P; University of Witwatersrand, Faculty of Health Sciences, Johannesburg, South Africa. Electronic address: pruff@iafrica.com., Ferry DR; Russells Hall Hospital, Dudley, UK., Lakomỳ R; Masaryk Memorial Cancer Institute, Brno, Czech Republic., Prausová J; Fakultni nemocnice v Motole, Praha, Czech Republic., Van Hazel GA; University of Western Australia, Western Australia, Australia., Hoff PM; Centro De Oncologia/Hospital Sirio Libanes, São Paulo, Brazil., Cunningham D; The Royal Marsden Hospital, Sutton, UK., Arnold D; Department of Medical Oncology, Tumor Biology Center, Freiburg, Germany., Schmoll HJ; Martin Luther University Halle-Wittenberg, Germany., Moiseyenko VM; Oncology Research Institute Na. NN. Petrov, St-Petersburg, Russian Federation., McKendrick JJ; Monash University, Victoria, Australia., Ten Tije AJ; Amphia Hospital, Breda, The Netherlands., Vishwanath RL; Sanofi Global Oncology Medical Affairs, Cambridge, MA, United States., Bhargava P; Sanofi Global Oncology Research and Development, Cambridge, MA, United States., Chevalier S; Sanofi, Vitry-sur-Seine, France., Macarulla T; Vall d'Hebron University Hospital and Institute of Oncology (VHIO), Universitat Autònoma de Barcelona, Barcelona, Spain., Van Cutsem E; University Hospitals Leuven and KU Leuven, Belgium.

Publikováno v: European journal of cancer (Oxford, England : 1990) [Eur J Cancer] 2015 Jan; Vol. 51 (1), pp. 18-26. Date of Electronic Publication: 2014 Nov 14.

Involvement of the ileocaecal region by non-Hodgkin's lymphoma in adults: clinical features and results of treatment.

Autor: Sweetenham, JW, Mead, GM, Wright, DH, McKendrick, JJ, Jones, DH, Williams, CJ, Whitehouse, JMA, Sweetenham, J W, Mead, G M, Wright, D H, McKendrick, J J, Jones, D H, Williams, C J, Whitehouse, J M

Publikováno v: British Journal of Cancer; Sep1989, Vol. 60 Issue 3, p366-369, 4p